查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750638

全球细胞培养维生素市场规模、份额、趋势分析报告：按产品、最终用途、地区和细分市场预测（2025-2030 年）

Cell Culture Vitamins Market Size, Share & Trends Analysis Report By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

细胞培养维生素市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，全球细胞培养维生素市场预计到 2030 年将达到 3.43 亿美元，2025 年至 2030 年的复合年增长率为 5.6%。

由于各个领域，尤其是生物製药研发领域对细胞培养技术的依赖日益增加，该市场正在经历显着成长。

推动细胞培养维生素市场成长的主要因素之一是生物技术和製药领域研发投入的大幅增加。各国政府、私人组织和学术机构正在加大对创新药物研发、疫苗研究以及基因和细胞治疗等先进治疗技术的投入。

新冠疫情对细胞培养维生素市场产生了重大影响。疫苗和生技药品的迫切需求加速了对高品质、可扩展的含维生素细胞培养补充剂的需求。这些补充剂对于确保快速稳定生产、支持研究以及实现高效的生产流程以满足全球疫苗需求至关重要。需求的激增凸显了细胞培养基配方在疫苗和治疗方法开发中的重要性。因此，疫情不仅加剧了对细胞培养维生素的迫切需求，也凸显了细胞培养维生素在生物製药製造中的关键作用，从而增强了市场的成长轨迹。

癌症、糖尿病和自体免疫疾病等慢性疾病的发生率不断上升，显着增加了对更先进、更有针对性的医疗保健解决方案的需求。由于传统治疗方法通常无法解决复杂且长期的病症，人们开始转向创新的生技药品和细胞治疗方法能够提供更个人化、更有效的治疗方案。这些先进的治疗方法在很大程度上依赖细胞培养技术，而维持健康、功能正常的细胞对于成功至关重要。为此，精确控制、营养丰富的培养环境至关重要，尤其是富含维生素的培养环境，这些维生素能够支持细胞生长、分化和免疫反应。

细胞培养维生素市场报告重点

  • 根据产品，B 群维生素部分将在 2024 年占据最大的收入份额，为 39.12%。市场受到生物製药製造和研究应用对高品质细胞培养基日益增长的需求的推动。
  • 根据最终用途，细胞培养基製造商部门将主导市场，占据 2024 年最大的收益占有率。生物製药公司和研究中心对优质富含维生素的培养基的需求日益增长，这对于生技药品、疫苗和细胞疗法的大规模生产至关重要，这推动了这一细分市场的扩张。
  • 2024年，北美占最大份额，达37.49%。北美在生物技术、医疗保健和药物开发领域处于领先地位，因此对细胞培养维生素的需求很高。该地区拥有顶尖的研究中心和公司，致力于开发疫苗、抗体疗法和细胞疗法，这些都需要高品质、富含维生素的培养基来高效培养细胞。

目录

第一章调查方法与范围

第二章执行摘要

第三章细胞培养维生素市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 细胞培养维生素市场的分析工具
    • 波特的分析
    • PESTEL分析
    • COVID-19影响分析

第四章细胞培养维生素市场：产品评估与趋势分析

  • 产品细分仪表板
  • 全球细胞培养维生素市场：产品差异分析
  • 2018-2030年全球细胞培养维生素市场规模及产品趋势分析
  • B群维生素
    • 维生素 B 复合物市场规模、预测和趋势分析（2018-2030 年）
  • 维生素A
    • 维生素 A 市场规模、预测与趋势分析（2018-2030 年）
  • 维生素C
    • 维生素 C 市场规模、预测与趋势分析（2018-2030 年）
  • 其他维生素
    • 其他维生素市场规模、预测和趋势分析（2018-2030 年）

第五章细胞培养维生素市场：最终用途估计与趋势分析

  • 最终用途细分仪表板
  • 全球细胞培养维生素市场：最终用途差异分析
  • 2018-2030 年全球细胞培养维生素市场规模及最终用途趋势分析
  • 细胞培养基製造商
    • 细胞培养基製造商的市场规模、预测与趋势分析（2018-2030年）
  • 製药和生物技术公司
    • 製药和生物技术公司的市场规模、预测和趋势分析（2018-2030 年）
  • CDMO/CMO和CRO
    • CDMO/CMO 和 CRO 市场规模、预测和趋势分析（2018-2030 年）

第六章细胞培养维生素市场：区域估计和趋势分析

  • 2024 年及 2030 年各地区市场占有率分析
  • 区域市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • DSM-Firmenich
    • Merck KGaA
    • Thermo Fisher Scientific
    • FUJIFILM Irvine Scientific
    • Lonza
    • HiMedia Laboratories
    • Danaher
    • Sartorius AG
    • Corning Inc.
    • R&D Systems（Bio-Techne）
Product Code: GVR-4-68040-585-3

Cell Culture Vitamins Market Growth & Trends:

The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development

One of the key drivers propelling the growth of the cell culture vitamins market is the significant rise in research and development (R&D) investments across the biotechnology and pharmaceutical sectors. Governments, private organizations, and academic institutions increasingly allocate funds to support innovative drug development, vaccine research, and advanced therapeutic techniques such as gene and cell therapies.

The COVID-19 pandemic has had a profound impact on the cell culture vitamins market. The urgent need for vaccines and biologics accelerated demand for high-quality, scalable cell culture supplements, including vitamins, which are critical in ensuring rapid and consistent production, supporting research, and enabling efficient manufacturing processes to meet global vaccine demand. This surge in demand underscored the importance of cell culture media formulations in vaccine and therapeutic development. Consequently, the pandemic not only amplified the immediate need for cell culture vitamins but also highlighted their essential role in biopharmaceutical manufacturing, thereby reinforcing the market's growth trajectory

The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has significantly increased the demand for more advanced and targeted healthcare solutions. As traditional treatments often fall short in addressing complex and long-term conditions, there is a growing shift toward innovative biologics and cell-based therapies that offer more personalized and effective approaches. These advanced therapies rely heavily on cell culture technologies, where maintaining healthy and functional cells is critical for success. To achieve this, precisely controlled, nutrient-rich culture environments become essential, particularly those enriched with vitamins that support cell growth, differentiation, and immune response.

Cell Culture Vitamins Market Report Highlights:

  • Based on product, the vitamin B complex segment accounted for the largest revenue share of 39.12% in 2024. The market is driven by increasing demand for high-quality cell culture media in biopharmaceutical manufacturing and research applications.
  • Based on end use, the cell culture media manufacturers segment dominated the market and accounted for the largest revenue share in 2024. Growing needs from biopharmaceutical firms and research centers for premium, vitamin-rich culture media, essential for mass production of biologics, vaccines, and cell therapies, are fueling this market segment's expansion.
  • North America held the largest share of 37.49% in 2024. North America has a high demand for cell culture vitamins because it leads in biotechnology, medicine, and drug development. The region is home to top research centers and companies that create vaccines, antibody treatments, and cell therapies, all of which need high-quality, vitamin-rich culture media to grow cells effectively.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Culture Vitamins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising demand for biopharmaceuticals
      • 3.2.1.2. Growing investment in R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Stringent regulatory requirements
  • 3.3. Cell Culture Vitamins Market Analysis Tools
    • 3.3.1. Porter's Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Culture Vitamins Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Cell Culture Vitamins Market Product Movement Analysis
  • 4.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cell Culture Vitamins
    • 4.4.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Vitamins
    • 4.5.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Cell Culture Vitamins Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Global Cell Culture Vitamins Market End Use Movement Analysis
  • 5.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture Media Manufacturers
    • 5.4.1. Cell Culture Media Manufacturers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Pharmaceutical & Biotechnology Companies
    • 5.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.6. CDMOs/ CMOs & CROs
    • 5.6.1. CDMOs/ CMOs & CROs Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Cell Culture Vitamins Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. DSM-Firmenich
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Thermo Fisher Scientific
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FUJIFILM Irvine Scientific
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Lonza
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. HiMedia Laboratories
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Sartorius AG
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Corning Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. R&D Systems (Bio-Techne)
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell culture vitamins market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico cell culture vitamins market, by end-use, 2018 - 2030 (USD Million))
  • Table 14 Europe cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 22 France cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Denmark cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Sweden cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Norway cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 China cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 39 China cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 India cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 41 India cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Thailand cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Latin America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Brazil cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 MEA cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 56 MEA cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 57 MEA cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture vitamins market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Cell culture vitamins market: Product outlook key takeaways
  • Fig. 20 Cell culture vitamins market: Product movement analysis
  • Fig. 21 Vitamin B complex market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Vitamin A market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin C market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell culture vitamins market: End-use outlook key takeaways
  • Fig. 26 Cell culture vitamins market: End-use movement analysis
  • Fig. 27 Cell culture media manufacturers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CDMOs/ CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America Cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Market participant categorization
  • Fig. 71 Cell culture vitamins market position analysis, 2024
  • Fig. 72 Strategic framework